Theralase Technologies Inc. V.TLT

Hot off the press!

[livermore2]

https://www.urotoday.com/video-lectures/aua-2023/video/mediaitem/3397-promising-developments-in-the-theralase-project-for-bcg-unresponsive-bladder-cancer-girish-kulkarni.html

[Eoganacht]

Great! Thanks livermore2. Fabulous interview.

[Eoganacht]

Our principle investigator, Dr. Kulkarni, interviewed by the sole remaining member of our Medical and Scientific Advisory Board, Dr. Kamat.

[Longholder99]

Great to see Dr Kamat getting involved and acknowledging Theralases achievements publicly. It's a good sign. Imo

[N0taP00p]

Now that's great coverage with the larger urology ecosystem outside the AUA.  It's great that Dr Kamat took the opportunity to explain why this PDT is different. Dr. Kulkarni seems like a humble and down to earth doctor/scientist.  I hope they see it through successfully, and soon.  

[ScienceFirst]

I knew such a coverage would be coming. Heard it from the best in the field; Dr. Kulkarni and Dr. Kamat We're officially introduced to the AUA clientele; the urologists Amazing. TLT is never cutting corners, always working with the best.  Once again.

[ScienceFirst]

Amazing catch Livermore2.  Thanks for sharing. Probably the reason why we had a "big" ASK until now.  Let's see if it goes away tomorrow.  No matter what, this is putting us on the map officially. Hats off to TLT management.

[ScienceFirst]

Ahead of FDA Breakthrough Therapy designation and ahead of up to 9 new CSS (clinical study sites). Expect MD-Anderson (Dr. Kamat's alma mater) to be among those new sites. Doing the right things, in the right order, without cutting corners.   I expect this interview to be given visibility by Bladder Cancer Canada, in one way or another, as it is their mandate to promote new

[ScienceFirst]

FDA Breakthrough will be a no brainer.   Do you really believe that both Dr. Kamat would go live on record in front of their AUA urologist colleagues for something that wouldn't stand a chance to succeed? I expect MD-Anderson Cancer Center, the #1 cancer center in the US over the last 20y, to be one of the 9 new upcoming CSS. ______________   livermore2 - (5/18

[ScienceFirst]

FDA Breakthrough will be a no brainer.   Do you really believe that both Dr. Kamat and Dr. Kulkarni would go live on record in front of their AUA urologist colleagues for something that wouldn't stand a chance to succeed? I expect MD-Anderson Cancer Center, the #1 cancer center in the US over the last 20y, to be one of the 9 new upcoming CSS. ______________  

[StevenBirch]

Dr. Kamat "and we hope that it pans out for our patients sake".  That should put an end to any fears that because it is a small Canadian company it will be buried. Nice work Livermore.

[CancerSlayer]

  Good science has no borders...it's recognition of science that too often divides.  The AUA video is a good start, but getting a major cancer center(s) (i.e. MD Anderson) to trial, support & possibly advance this ACT is a difference maker. In the meantime, any baby steps are welcome.

[Oilminerdeluxe]

Wonderful interview! Thanks for posting i.

[Oilminerdeluxe]

The question starting around the 3,00 min mark, oh, how all could have been explosive if Dr Kulkarni had given a different answer. Not that the one he gave was bad. I suspect he can't say too much, but if he had, I think we could have been doing a happy dance. Maybe we will soon anyway. Hope so. Again, many thanks for posting the interview

[Lesalpes29]

Thank you Livermore and other posters for posting this positive video. GL

[ScienceFirst]

While some were complaining recently that management was incompetent and lacking transparency despite all the info./roadmap we got since Jan. 3rd, this interview was already planned well in advance. Of course, such events cannot be disclosed in advance.   And one has to understand that we're involved in a very conservative industry driven by data.  So very difficult to convince. &

[N0taP00p]

@SF: Being a conservative industry has NOTHING to do with updating investors about important milestones. Being emotionally invested takes away our objectivity.   Immunity Bio had no qualms about telling investors they had submitted a BLA, for example.  As for TLT, it is as simple as saying "we intended to submit in Q4'22, but for abc reasons, we  needed to push this

[ScienceFirst]

NP ... They post what is material.  Positive or not.  For the rest, that's normal course of business.  And they inform us when situations dictate an update, when they have all the info. to make a sounded update.  So far, so good.  We all know where they're heading.  They informed us that they were working with a statistician and regulatory body in regards to

[N0taP00p]

Fair enough, SF. Yes, I like to receive a bit more info about my investments directly without guesswork. I see your point, and hope the reason for limited info is positive developments vs a surprise negative.